Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
Ascentage Pharma and AstraZeneca Enter into Clinical Collaboration on the Registrational Phase III Study of Bcl-2 Inhibitor Lisaftoclax in Combination with BTK Inhibitor Acalabrutinib in Treatment-Naïve Patients with First-Line CLL/SLL 2023-10-16 09:23
Sozo Aesthetic Clinic, Raffles Place in Singapore, Introduces Updated Scars Treatment Protocol 2023-10-16 09:01
Everest Medicines' Licensing Partner Pfizer Announces U.S. FDA Approves Etrasimod for Adults with Moderately to Severely Active Ulcerative Colitis 2023-10-16 07:48
UEG Week 2023: Babies with a low birthweight four times more likely to develop fatty liver disease in later life 2023-10-16 06:01
HEALTHSCOPE : AI ENABLES PATIENT EMOTIONS TO BE ANALYSED IMPROVING HOSPITAL EXPERIENCE. 2023-10-16 04:00
Sihuan Pharmaceutical Was Selected As One Of The First Echelon Of Enterprises In The list of China's Top 100 Pharmaceutical Innovative Enterprises in 2023 2023-10-14 20:09
LifeSpan Vision Ventures Makes 7th Investment in Pursuit of Longevity Mission 2023-10-14 04:54
Nona Biosciences and INGENIA Therapeutics Enter into Collaboration Agreement 2023-10-13 23:26
Offering broader access to sustainable and scalable pharma-grade saponin adjuvants 2023-10-13 21:47
Inmagene Doses First Patient in Phase 2a Trial of IMG-007, an Anti-OX40 Monoclonal Antibody with an Extended Half-life, for the Treatment of Alopecia Areata 2023-10-13 20:00
World Thrombosis Day encourages public to "Move Against Thrombosis" to celebrate 10 years of raising awareness worldwide 2023-10-13 15:00
Hilton Properties in Malaysia Invites All To Sip, Savor and Support This Pinktober 2023-10-13 13:30
SK Biopharmaceuticals' Proteovant Therapeutics Presents Preclinical Data at the AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics 2023-10-13 09:00
GenScript ProBio Congratulates ABL Bio's IND Clearance of ABL103 Program from MFDS 2023-10-13 09:00
Global Registrational Phase III Study of Bcl-2 Inhibitor Lisaftoclax in Treatment-Naïve Patients with CLL/SLL Approved by the China CDE 2023-10-13 08:22
Specialised Therapeutics signs exclusive license agreement with CanariaBio for new ovarian cancer therapy 2023-10-13 03:00
M42 Announces New Clinical LLM to Transform the Future of AI in Healthcare 2023-10-13 01:26
Discovery Life Sciences Announces Major Strategic Expansions: New State-of-the-Art Facilities, Advanced Technologies, and Global Brand Enhancements 2023-10-12 22:00
CARsgen's CAR-GPC3 T-cell Therapy for Advanced Hepatocellular Carcinoma: Two Patients Achieved over 7 Years of Disease-free Survival 2023-10-12 20:50
Emulate Earns Frost & Sullivan's 2023 Technology Innovation Leadership Award 2023-10-12 20:00
1 94 95 96 97 98 1508